Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 6
1967 4
1968 10
1969 9
1970 7
1971 3
1972 7
1973 4
1974 11
1975 8
1976 8
1977 8
1978 10
1979 12
1980 6
1981 8
1982 9
1983 7
1984 4
1985 5
1986 7
1987 8
1988 2
1989 7
1990 16
1991 9
1992 10
1993 8
1994 21
1995 10
1996 16
1997 18
1998 18
1999 18
2000 16
2001 18
2002 12
2003 6
2004 11
2005 20
2006 16
2007 20
2008 14
2009 16
2010 17
2011 20
2012 20
2013 24
2014 22
2015 14
2016 11
2017 8
2018 10
2019 8
2020 13
2021 7
2022 10
2023 8
2024 6
2025 2
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

641 results

Results by year

Filters applied: . Clear all
Page 1
Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam.
Fox GJ, Nhung NV, Cam Binh N, Hoa NB, Garden FL, Benedetti A, Ngoc Yen P, Cuong NK, MacLean EL, Yapa HM, Dowdy DW, Lan NH, Guevara-Rattray E, Duc Cuong P, Solomon O, Behr MA, Marais BJ, Graham SM, Menzies D, Thu Anh N, Marks GB. Fox GJ, et al. N Engl J Med. 2024 Dec 19;391(24):2304-2314. doi: 10.1056/NEJMoa2314325. N Engl J Med. 2024. PMID: 39693541 Clinical Trial.
The trial population comprised household contacts of persons with bacteriologically confirmed rifampicin-resistant or multidrug-resistant (MDR) tuberculosis in Vietnam. Contacts of any age with a positive tuberculin skin test or immunologic impairment were eligible. The pr …
The trial population comprised household contacts of persons with bacteriologically confirmed rifampicin-resistant or multidrug-resistant (M …
Bladder cancer immunotherapy.
Lamm DL, Thor DE, Stogdill VD, Radwin HM. Lamm DL, et al. J Urol. 1982 Nov;128(5):931-5. doi: 10.1016/s0022-5347(17)53283-8. J Urol. 1982. PMID: 6757467 Clinical Trial.
The interval free of disease was prolonged significantly with bacillus Calmette-Guerin treatment (p equals 0.014, generalized Wilcoxon test). Importantly, a simple purified protein derivative skin test distinguished those patients who responded to bacillus Ca …
The interval free of disease was prolonged significantly with bacillus Calmette-Guerin treatment (p equals 0.014, generalized Wilcoxon test) …
Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S, Namasondhi A, Pomsoong C, Kositkuljorn C, Anuntrangsee T, Thadanipon K. Rutnin S, et al. Dermatology. 2023;239(1):109-115. doi: 10.1159/000526601. Epub 2022 Oct 25. Dermatology. 2023. PMID: 36282051 Free article. Clinical Trial.
However, evidence on comparative effects between intralesional immunotherapy with measles, mumps, rubella vaccine (MMR) and tuberculin purified protein derivative (PPD) and roles of dermoscopy in predicting treatment outcomes in palmoplantar/periungual …
However, evidence on comparative effects between intralesional immunotherapy with measles, mumps, rubella vaccine (MMR) and tuberculin …
Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study.
Zaky MS, Atallah RB, Mohyeldeen AMS, Elsaie ML. Zaky MS, et al. Sci Rep. 2024 Jan 2;14(1):288. doi: 10.1038/s41598-023-49182-2. Sci Rep. 2024. PMID: 38167543 Free PMC article. Clinical Trial.
To evaluate safety and efficacy of intralesional injection of tuberculin purified protein derivative (PPD) antigen injection versus MMR (mumps, measles, rubella) antigen for the treatment of molluscum contagiosum (MC). ...We established a good safety a …
To evaluate safety and efficacy of intralesional injection of tuberculin purified protein derivative (PPD) antig …
Efficacy and safety of intralesional tuberculin purified protein derivative versus cryotherapy in the treatment of warts: An assessor-blinded, randomized controlled trial.
Wan Ahmad Kammal WSL, Jamil A, Md Nor N. Wan Ahmad Kammal WSL, et al. Dermatol Ther. 2021 Sep;34(5):e15080. doi: 10.1111/dth.15080. Epub 2021 Aug 12. Dermatol Ther. 2021. PMID: 34351693 Clinical Trial.
Cryotherapy is a standard treatment for warts. Tuberculin immunotherapy is a novel therapeutic option. We compared the efficacy and safety of cryotherapy versus tuberculin immunotherapy in a randomized, assessor-blinded study. 15 patients were treated with intralesi …
Cryotherapy is a standard treatment for warts. Tuberculin immunotherapy is a novel therapeutic option. We compared the efficacy and s …
A double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with Mycobacterium w vaccine in the treatment of multiple viral warts.
Chandra S, Sil A, Datta A, Pal S, Das NK. Chandra S, et al. Indian J Dermatol Venereol Leprol. 2019 Jul-Aug;85(4):355-366. doi: 10.4103/ijdvl.IJDVL_549_18. Indian J Dermatol Venereol Leprol. 2019. PMID: 31172979 Free article. Clinical Trial.
AIMS: This study aimed at comparing efficacy and safety of and quality of life changes with intradermal purified protein derivative (PPD) of tuberculin antigen and Mycobacterium w (Mw) vaccine in immunotherapy of warts. ...CONCLUSION: Intradermal injec …
AIMS: This study aimed at comparing efficacy and safety of and quality of life changes with intradermal purified protein de …
Combined intralesional injection of tuberculin purified protein derivative plus cryotherapy versus each alone in the treatment of multiple common warts.
Ibrahim H, El Taieb M, Nada E, Kamal E, Hegazy E. Ibrahim H, et al. Dermatol Ther. 2022 Apr;35(4):e15350. doi: 10.1111/dth.15350. Epub 2022 Feb 13. Dermatol Ther. 2022. PMID: 35103366 Clinical Trial.
We aim to compare the effect of cryotherapy, intralesional injection of tuberculin purified protein derivative (PPD) and cryotherapy combined with intralesional injection of tuberculin PPD in the treatment of multiple common warts. ...However, t …
We aim to compare the effect of cryotherapy, intralesional injection of tuberculin purified protein derivative ( …
Preventive therapy of tuberculosis.
Brummer DL. Brummer DL. Annu Rev Med. 1974;25:115-22. doi: 10.1146/annurev.me.25.020174.000555. Annu Rev Med. 1974. PMID: 4596225 Review. No abstract available.
Intralesional immunotherapy with tuberculin purified protein derivative (PPD) in recalcitrant wart: A randomized, placebo-controlled, double-blind clinical trial including an extra group of candidates for cryotherapy.
Amirnia M, Khodaeiani E, Fouladi DF, Masoudnia S. Amirnia M, et al. J Dermatolog Treat. 2016;27(2):173-8. doi: 10.3109/09546634.2015.1078871. Epub 2015 Sep 7. J Dermatolog Treat. 2016. PMID: 26295565 Free article. Clinical Trial.
OBJECTIVE: To examine the efficacy and safety of intralesional immunotherapy with tuberculin purified protein derivative (PPD) for treating recalcitrant wart. METHODS: In this randomized, placebo-controlled, double-blind clinical trial, a total of 69 p …
OBJECTIVE: To examine the efficacy and safety of intralesional immunotherapy with tuberculin purified protein deriva …
Immunotherapy in viral warts with intradermal Bacillus Calmette-Guerin vaccine versus intradermal tuberculin purified protein derivative: A double-blind, randomized controlled trial comparing effectiveness and safety in a tertiary care center in Eastern India.
Podder I, Bhattacharya S, Mishra V, Sarkar TK, Chandra S, Sil A, Pal S, Kumar D, Saha A, Shome K, Bandyopadhyay D, Das NK. Podder I, et al. Indian J Dermatol Venereol Leprol. 2017 May-Jun;83(3):411. doi: 10.4103/0378-6323.193623. Indian J Dermatol Venereol Leprol. 2017. PMID: 27852999 Free article. Clinical Trial.
AIMS: The aim of this study was to compare the effectiveness and safety of Bacillus Calmette-Guerin vaccine versus tuberculin purified protein derivative in the immunotherapy of warts. METHODS: Patients received three doses of 0.1 ml of Bacillus Calmet …
AIMS: The aim of this study was to compare the effectiveness and safety of Bacillus Calmette-Guerin vaccine versus tuberculin puri …
641 results